M32.12

Pericarditis occurring as a direct manifestation of systemic lupus erythematosus, classified under SLE with organ or system involvement (parent M32.1).

Verified May 8, 2026 · 6 sources ↓

Status: Billable
Chapter: 13
Related CPT: 6
Region: General

Drawn from CDCICD10DataAAPCOutsourcestrategiesThe-rheumatologist

Documentation tips

What should appear in the chart to support M32.12.

Source · Editorial brief grounded in 6 cited references ↓

Provider must explicitly link pericarditis to SLE — phrases like 'lupus pericarditis' or 'pericarditis due to SLE' satisfy the causal connection required for M32.12.
Document supporting diagnostic evidence: echocardiographic findings (pericardial effusion, thickening), ECG changes, or elevated inflammatory markers in the context of active SLE.
Record active SLE disease markers where available — positive ANA, anti-dsDNA titers, complement levels — to substantiate the autoimmune etiology rather than an infectious or idiopathic cause.
If pericardial effusion is also present, document it separately so it can be coded as an additional diagnosis (e.g., I31.3) for full capture of clinical complexity and CC/MCC impact.
Note current treatment including immunosuppressants, NSAIDs, or colchicine, as medication context supports medical necessity and may affect risk-adjustment models.

Related CPT procedures

Procedure codes commonly billed with M32.12. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

99213 $95.19

Established patient office or outpatient visit requiring 20–29 minutes of total time or low-complexity medical decision-making.

99214 $135.61

Office visit for an established patient requiring moderate-complexity medical decision making (MDM), or 30–39 minutes of total provider time on the date of service.

99215 $192.39

Highest-level office or outpatient E/M visit for an established patient, qualifying via high-complexity medical decision making or 40–54 minutes of total provider time on the date of service.

93306 View procedure details

93350 View procedure details

71046 View procedure details

Common coding pitfalls

The recurring mistakes coders make with M32.12 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

Assigning M32.12 when pericarditis etiology is unconfirmed or documented only as 'possible' — pending workup should default to M32.10 (organ involvement unspecified) until the link to SLE is established.
Using M32.12 for discoid lupus erythematosus patients — the Excludes1 note at the M32 category level prohibits this; discoid lupus codes to L93.0.
Defaulting to M32.9 (SLE unspecified) out of habit when the provider has clearly documented pericarditis as a lupus manifestation — M32.12 is the more specific and correct code.
Failing to code pericardial effusion separately when documented, which may constitute a CC and elevate the MS-DRG assignment.
Confusing M32.12 with M32.11 (endocarditis in SLE) — pericarditis involves the pericardial sac; endocarditis involves the heart valves. The distinction must be supported by clinical documentation and imaging.

Clinical context

Source · Editorial summary grounded in 6 cited references ↓

M32.12 is the billable code for lupus pericarditis — inflammation of the pericardial sac causally attributed to SLE, not to an independent infectious or idiopathic etiology. Use it only when the provider explicitly documents pericarditis as a manifestation of SLE. It sits under M32.1 (SLE with organ or system involvement), so the cardiac involvement must be confirmed, not suspected.

Do not use M32.12 for general SLE without documented cardiac involvement — that belongs to M32.9 (unspecified) or M32.10 (organ involvement unspecified, when workup is still pending). Also note the category-level Excludes1 instruction: discoid lupus erythematosus (L93.0) is explicitly excluded from the entire M32 category — M32.12 is appropriate only for systemic, not discoid, disease.

This code groups into MS-DRG v43.0 clusters 545–547 (Connective tissue disorders with/without MCC/CC), so complication and comorbidity documentation directly affects DRG assignment and reimbursement tier. Code additional manifestations separately when they are not captured within the M32.12 description — for example, pericardial effusion (I31.3) if documented.

Inclusion & exclusion notes

Per the official ICD-10-CM Tabular List.

Source · CDC ICD-10-CM Official Tabular List · 2026

Includes

Lupus pericarditis

Sibling codes

Other billable codes under M32.1 (laterality / anatomic variants).

M32.19

Oth organ or system involv in systemic lupus erythematosus

M32.14

Glomerular disease in systemic lupus erythematosus

M32.10

Systemic lupus erythematosus, organ or system involv unsp

M32.11

Endocarditis in systemic lupus erythematosus

M32.15

Tubulo-interstitial nephrop in sys lupus erythematosus

M32.13

Lung involvement in systemic lupus erythematosus

Frequently asked questions

Source · Generated from the editorial pipeline, verified against 6 cited references ↓

01Can I use M32.12 if the provider documents 'pericarditis in a patient with SLE' without explicitly stating the two are related?

Not reliably. ICD-10-CM coding guidelines require a documented causal relationship. If the provider hasn't linked the conditions, query for clarification before assigning M32.12. Without that link, M32.9 or a standalone pericarditis code may be more defensible.

02Should I also code the underlying SLE separately when using M32.12?

No. M32.12 is a combination code that captures both the SLE and the pericarditis manifestation. Assigning M32.9 or M32.10 alongside M32.12 for the same encounter is redundant and incorrect.

03What is the difference between M32.11 and M32.12?

M32.11 is endocarditis in SLE (valve-level inflammation); M32.12 is pericarditis in SLE (pericardial sac inflammation). The distinction requires clear documentation and imaging support — do not interchange based on generic 'cardiac involvement' language.

04Is pericardial effusion captured within M32.12, or does it need a separate code?

Pericardial effusion is not captured within M32.12. If the provider documents it as a co-existing finding, code it separately (e.g., I31.3 — pericardial effusion, non-inflammatory). This may qualify as a CC and affect DRG assignment.

05Does M32.12 apply to drug-induced lupus with pericarditis?

No. Drug-induced SLE codes to M32.0. M32.12 is under the M32.1 branch, which covers idiopathic systemic lupus with organ involvement. If the lupus is drug-induced and pericarditis is present, use M32.0 and code the pericarditis separately, or query whether M32.19 better captures the full picture pending official guidance.

06What MS-DRG does M32.12 map to?

M32.12 groups to MS-DRG v43.0 clusters 545 (with MCC), 546 (with CC), or 547 (without CC/MCC). Thorough documentation of comorbidities and complications is critical to landing in the correct tier.

07Is there a laterality consideration for M32.12?

No. The pericardium is a single midline structure, so laterality does not apply to this code. No 6th-character laterality modifier exists within M32.12.

Sources & references

Editorial content was developed using the following public sources. Last verified May 8, 2026.

Mira AI Scribe

Mira captures the provider's explicit attribution of pericarditis to SLE, relevant echo or ECG findings, active SLE serologic markers, and current immunosuppressive therapy. This prevents a fallback to M32.9 or M32.10, protects the CC/MCC tier under MS-DRG 545–547, and closes the audit gap created when pericarditis is documented without a documented causal link to SLE.

See how Mira captures M32.12 documentation